Related Experiment Video

Updated: Sep 19, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Clinical course of whooping cough in children younger than six months

B Trollfors

    Acta Paediatrica Scandinavica
    |May 1, 1979
    PubMed

    Insights

    Erythromycin treatment in the early catarrhal stage of pertussis in infants showed a trend toward milder illness, but results were not statistically significant. Most infants with pertussis experienced mild disease, with few requiring hospitalization.

    Area of Science:

    • Pediatrics
    • Infectious Diseases
    • Microbiology

    Background:

    • Pertussis, or whooping cough, remains a significant concern in infants.
    • Early diagnosis and treatment are crucial for managing pertussis in young children.

    Purpose of the Study:

    • To analyze the clinical presentation and outcomes of pertussis in infants.
    • To evaluate the efficacy of erythromycin treatment during the catarrhal stage.

    Main Methods:

    • Retrospective analysis of patient records for 59 infants (2-26 weeks) with culture-verified pertussis.
    • Categorization of patients based on hospitalization status and treatment with erythromycin.
    • Assessment of disease severity and clinical outcomes.

    Main Results:

    • Most infants (59) with pertussis experienced mild disease; only one required critical care.
    • Hospitalization was often for social reasons, not medical necessity.
    • Erythromycin treatment in the catarrhal stage showed a trend towards milder disease, though not statistically significant compared to untreated infants.

    Conclusions:

    • Pertussis in infants aged 2-26 weeks is often mild, with limited need for hospitalization.
    • Erythromycin treatment during the early catarrhal stage may offer a clinical benefit, warranting further investigation.
    • Prompt diagnosis and management are essential for optimizing outcomes in infant pertussis.

    More Related Videos

    A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice07:43

    A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice

    Published on: September 28, 2016

    A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness12:21

    A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

    Published on: September 28, 2022

    Related Concept Videos

    Pulmonary Cycle: Exhalation01:17

    Pulmonary Cycle: Exhalation

    In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
    Pneumonia I: Introduction01:30

    Pneumonia I: Introduction

    Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
    Risk Factors
    Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
    Pneumonia II: Pathophysiology01:29

    Pneumonia II: Pathophysiology

    The pathophysiology of pneumonia involves the following steps:
    Respiratory Syncytial Virus Disease01:29

    Respiratory Syncytial Virus Disease

    Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
    Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

    Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

    Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
    Pneumonia I: Introduction01:29

    Pneumonia I: Introduction

    Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...